Table 1.
Summary statistics (mean and SD) and group differences for demographic and clinical measures.
| Full sample | HCs (N = 49) |
DEP/ANX (N = 192) |
SUDs (N = 84) |
p* |
|---|---|---|---|---|
| Age | 32.71 (11.29) | 37.17 (11.42) | 36.28 (9.18) | 0.039 |
| Sex (% male) | 24 (49.0%) | 50 (26.0%) | 34 (40.5%) | 0.002 |
| PHQ baseline | 0.85 (1.27) | 12.57 (5.19) | 6.88 (6.10) | < 0.001 |
| PHQ 1-year follow-up | 1.14 (1.84) | 8.27 (6.10) | 3.10 (4.57) | < 0.001 |
| OASIS baseline | 1.38 (2.00) | 9.74 (3.47) | 5.98 (4.86) | < 0.001 |
| OASIS 1-year follow-up | 1.47 (2.31) | 7.56 (4.58) | 3.54 (4.36) | < 0.001 |
| DAST-10 Baseline | 0.12 (0.39) | 0.56 (1.27) | 7.46 (2.21) | < 0.001 |
| DAST-10 1-year follow-up | 0.47 (0.56) | 0.56 (1.05) | 2.46 (2.89) | < 0.001 |
| WRAT baseline | 63.89 (4.54) | 63.03 (4.64) | 58.49 (6.00) | < 0.001 |
| Matched sample | HCs (N = 48) |
DEP/ANX (N = 121) |
SUDs (N = 29) |
p |
|---|---|---|---|---|
| Age | 32.94 (11.29) | 36.46 (11.13) | 34.06 (9.93) | 0.144 |
| Sex (% male) | 24 (50.0%) | 31 (25.6%) | 13 (44.8%) | 0.005 |
| PHQ baseline | 0.85 (1.27) | 12.57 (5.34) | 8.69 (7.49) | < 0.001 |
| PHQ 1-year follow-up | 1.14 (1.84) | 8.10 (6.44) | 4.03 (4.12) | < 0.001 |
| OASIS baseline | 1.38 (2.00) | 9.71 (3.44) | 6.93 (5.52) | < 0.001 |
| OASIS 1-year follow-up | 1.47 (2.31) | 7.26 (4.53) | 4.52 (4.40) | < 0.001 |
| DAST-10 Baseline | 0.12 (0.39) | 0.53 (1.18) | 7.52 (2.69) | < 0.001 |
| DAST-10 1-year follow-up | 0.47 (0.56) | 0.56 (1.18) | 2.69 (2.97) | < 0.001 |
| WRAT baseline | 63.89 (4.54) | 62.88 (4.60) | 61.59 (5.34) | 0.123 |
*Based on ANOVAs testing for the presence of differences between groups.